MAPK14 and chronic myelogenous leukemia, BCR-ABL1 positive: p38 inhibition decreased CML-collagen-induced apoptosis 34%, and the JNK inhibitor decreased apoptosis by 41%, both of which were statistically significant (p<0.05; Figure 4C).